MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL)
Clinical trials for MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL) explained in plain language.
Never miss a new study
Get alerted when new MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL) trials appear
Sign up with your email to follow new studies for MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart valve device offers hope for patients too sick for surgery
Disease control Recruiting nowThis study tests a new device called the INNOVALVE system to fix leaky heart valves (mitral regurgitation) without open-heart surgery. It includes 65 people who are at high risk for surgery. The goal is to see if the device is safe and works well.
Matched conditions: MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL)
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated May 26, 2026 10:08 UTC
-
Tiny heart-valve fix tested in just 5 patients
Disease control Recruiting nowThis early study tests a new tool called CathHELIX™ that aims to repair a leaky mitral valve using a thin tube (catheter) instead of open-heart surgery. It will enroll 5 adults with moderate-to-severe or severe mitral regurgitation who have symptoms like shortness of breath or fa…
Matched conditions: MITRAL VALVE REGURGITATION (DEGENERATIVE OR FUNCTIONAL)
Phase: NA • Sponsor: HVR Cardio Oy • Aim: Disease control
Last updated May 18, 2026 12:00 UTC